Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases

被引:46
作者
Cobb, J. [1 ,2 ]
Cule, E. [3 ]
Moncrieffe, H. [4 ]
Hinks, A. [1 ]
Ursu, S. [4 ]
Patrick, F. [4 ]
Kassoumeri, L. [4 ]
Flynn, E. [1 ]
Bulatovic, M. [5 ]
Wulffraat, N. [5 ]
van Zelst, B. [6 ]
de Jonge, R. [6 ]
Bohm, M. [7 ,8 ]
Dolezalova, P. [7 ,8 ]
Hirani, S. [9 ]
Newman, S. [9 ]
Whitworth, P. [10 ]
Southwood, T. R. [10 ]
De Iorio, M. [11 ]
Wedderburn, L. R. [4 ,12 ]
Thomson, W. [1 ,2 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Arthrit Res UK,Ctr Genet & Genom,Inst Inflammat &, Manchester, Lancs, England
[2] Cent Manchester Natl Hlth Serv Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England
[4] UCL Inst Child Hlth, Rheumatol Unit, London, England
[5] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Immunol, Utrecht, Netherlands
[6] Erasmus Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands
[7] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[8] Charles Univ Prague, Gen Fac Hosp, Prague, Czech Republic
[9] City Univ London, Sch Hlth Sci, Ctr Hlth Serv Res, London EC1V 0HB, England
[10] Birmingham Childrens Hosp, Inst Child Hlth, Birmingham, W Midlands, England
[11] UCL, Dept Stat Sci, London, England
[12] UCL Inst Child Hlth, Arthrit Res UK, Ctr Adolescent Rheumatol, London, England
关键词
juvenile idiopathic arthritis; methotrexate; pharmacogenetics; response; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; ASSOCIATION; POLYMORPHISMS; EFFICACY; PHARMACOGENETICS; CLASSIFICATION; CATEGORIES; EXPRESSION; VARIANTS;
D O I
10.1038/tpj.2014.3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Clinical response to methotrexate (MTX) treatment for children with juvenile idiopathic arthritis (JIA) displays considerable heterogeneity. Currently, there are no reliable predictors to identify non-responders: earlier identification could lead to a targeted treatment. We genotyped 759 JIA cases from the UK, the Netherlands and Czech Republic. Clinical variables were measured at baseline and 6 months after start of the treatment. In Phase I analysis, samples were analysed for the association with MTX response using ordinal regression of ACR-pedi categories and linear regression of change in clinical variables, and identified 31 genetic regions (P<0.001). Phase II analysis increased SNP density in the most strongly associated regions, identifying 14 regions (P < 1 x 10(-5)): three contain genes of particular biological interest (ZMIZ1, TGIF1 and CFTR). These data suggest a role for novel pathways in MTX response and further investigations within associated regions will help to reach our goal of predicting response to MTX in JIA.
引用
收藏
页码:356 / 364
页数:9
相关论文
共 47 条
  • [1] Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study
    Adib, N.
    Hyrich, K.
    Thornton, J.
    Lunt, M.
    Davidson, J.
    Gardner-Medwin, J.
    Foster, H.
    Baildam, E.
    Wedderburn, L.
    Thomson, W.
    [J]. RHEUMATOLOGY, 2008, 47 (07) : 991 - 995
  • [2] Juvenile Idiopathic Arthritis New Insights into Classification, Measures of Outcome, and Pharmacotherapy
    Beresford, Michael W.
    [J]. PEDIATRIC DRUGS, 2011, 13 (03) : 161 - 173
  • [3] 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
    Beukelman, Timothy
    Patkar, Nivedita M.
    Saag, Kenneth G.
    Tolleson-Rinehart, Sue
    Cron, Randy Q.
    DeWitt, Esi Morgan
    Ilowite, Norman T.
    Kimura, Yukiko
    Laxer, Ronald M.
    Lovell, Daniel J.
    Martini, Alberto
    Rabinovich, C. Egla
    Ruperto, Nicolino
    [J]. ARTHRITIS CARE & RESEARCH, 2011, 63 (04) : 465 - 482
  • [4] Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
    Bulatovic, Maja
    Heijstek, Marloes W.
    Van Dijkhuizen, E. H. Pieter
    Wulffraat, Nico M.
    Pluijm, Saskia M. F.
    de Jonge, Robert
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (09) : 1484 - 1489
  • [5] Comabella M, 2009, ARCH NEUROL-CHICAGO, V66, P972, DOI 10.1001/archneurol.2009.150
  • [6] Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters
    Conseil, G
    Deeley, RG
    Cole, SPC
    [J]. PHARMACOGENETICS AND GENOMICS, 2005, 15 (08) : 523 - 533
  • [7] Genome-wide association studies in pharmacogenomics
    Daly, Ann K.
    [J]. NATURE REVIEWS GENETICS, 2010, 11 (04) : 241 - 246
  • [8] Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
    de Kleer, IM
    Brinkman, DMC
    Ferster, A
    Abinun, M
    Quartier, P
    van der Net, J
    ten Cate, R
    Wedderburn, LR
    Horneff, G
    Oppermann, J
    Zintl, F
    Foster, HE
    Prieur, AM
    Fasth, A
    van Rossum, MAJ
    Kuis, W
    Wulffraat, NM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) : 1318 - 1326
  • [9] ABCB1 and ABCC3 Gene Polymorphisms Are Associated with First-year Response to Methotrexate in Juvenile Idiopathic Arthritis
    de Rotte, Maurits C. F. J.
    Bulatovic, Maja
    Heijstek, Marloes W.
    Jansen, Gerrit
    Heil, Sandra G.
    van Schaik, Ron H. N.
    Wulffraat, Nico M.
    de Jonge, Robert
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (10) : 2032 - 2040
  • [10] Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]